A Lecturer from the Department of Biology Publishes a Global Study on Assessing Blood Glucose and Lipid Levels in Hypothyroid Patients Receiving Levothyroxine Treatment

Publishing a Scientific Study

Lecturer Dr. Dhu al-Fiqar Abbas Mutab from the Department of Biology published a scientific study titled “Assessment of Blood Glucose and Lipid Levels in Hypothyroid Patients Receiving Levothyroxine Treatment” in the Journal of Healthcare and Biology Research.
The study aimed to study hypothyroidism as a common disease in Iraq. Therefore, this study was designed to measure lipid levels in addition to glucose levels in 60 individuals (47 women and 13 men) suffering from hypothyroidism.
The study also included distributing patients across three regions in Kerbala Governorate. Based on hypothyroidism and clinical symptoms, the patients were analyzed to measure their blood lipid and glucose levels. The results showed that, compared to healthy individuals, the levels of the thyroid hormones T3 and T4 were 1.47, 1.72, 180.3, and 86.5 ng/ml, respectively. The levels of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) were lower, and the TSH level was higher. The TSH level was 10.08 ng/ml, compared to the normal 1.5 ng/ml. With the exception of triglycerides, the study found a lower body fat profile. Compared with healthy individuals (Cho: 195.8 mg/dl), TG: 168.8 mg/dl, HDL (46.7 mg/dl), LDL (79.6 mg/dl), and VLDL (31.0 mg/dl), hypothyroid patients had higher levels of cholesterol (185.3 mg/dl), triglycerides (183.9 mg/dl), HDL (43.7 mg/dl), LDL (82.0 mg/dl), and VLDL (34.0 mg/dl). Furthermore, there was no significant difference in glucose levels between patients and healthy individuals (119.5 and 118 mg/dl, respectively). The results also showed no statistically significant relationship between age and thyroid hormone levels, as well as between lipid profile and blood sugar levels between hypothyroid patients and healthy controls. The results also showed that women suffer from thyroid disorders more than men.